Sanofi-Aventis to invest in R&D in Spain
Business Investments
01 Apr 2012
France-based pharmaceutical company Sanofi-aventis plans to invest $1.3 million in research and development (R&D) projects of Barcelona's international biomedical research institute CRG.
The projects include cell reprogramming, the application of synthetic biology technology to treat lung diseases, the influence of genes as factor for some diseases and tuberculosis treatment, the director of CRG, Luis Serrano, said.
Source: IPA WORLD, 8/3/2012
Related News and Success stories.
-
07 May 2025
See more Barcelona, named Europe’s 4th Best City in 2025Barcelona, named Europe’s 4th Best City in 2025
-
23 Apr 2025
See more Multinational company Sanofi will open an innovation center in Barcelona, creating 300 jobsMultinational company Sanofi will open an innovation center in Barcelona, creating 300 jobs
-
22 Apr 2025
See more Solo Midocean to open a logistics hub in Tarragona, creating over 250 jobsSolo Midocean to open a logistics hub in Tarragona, creating over 250 jobs
-
16 Apr 2025
See more Transmesa invests €15M to produce new components for hybrid and hydrogen vehiclesTransmesa invests €15M to produce new components for hybrid and hydrogen vehicles
